Anika Therapeutics (ANIK) Revenue (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Revenue of $32.6 million for Q2 2026, up 15.56% year-over-year from $28.2 million in Q2 2025, and up 10.12% quarter-over-quarter from $29.6 million in Q1 2026.
Anika Therapeutics (ANIK) Revenue (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Revenue for 17 consecutive years, with $32.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Revenue rose 15.56% year-over-year to $32.6 million; the TTM figure through Jun 2026 stood at $120.7 million (up 5.33% YoY), while the FY2025 annual figure was $112.8 million, down 5.91% from the prior year.
- Revenue advanced to $32.6 million in Q2 2026 per ANIK's latest filing, from $29.6 million in the prior quarter.
- Across five years, Revenue topped out at $44.3 million in Q2 2023 and bottomed at -$2.9 million in Q4 2023.
- Historically, Revenue has averaged $29.4 million across 5 years, with a median of $30.6 million in 2024.
- Annual changes were most pronounced in 2022 — Revenue plunged 107.78% — and 2024, when it soared 1155.61%.
- Anika Therapeutics' Revenue stood at -$2.8 million in 2022, then decreased by 4.02% to -$2.9 million in 2023, then jumped by 1155.61% to $30.6 million in 2024, then advanced by 0.04% to $30.6 million in 2025, then climbed by 6.52% to $32.6 million in 2026.
- Business Quant data shows ANIK's Revenue at $32.6 million in Q2 2026, $29.6 million in Q1 2026, and $30.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Anika Therapeutics | 283.93 Mn | 245.52 Mn | 21.24 Mn | 32.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.61 Mn |
| Mar 31, 2026 | 29.61 Mn |
| Dec 31, 2025 | 30.62 Mn |
| Sep 30, 2025 | 27.82 Mn |
| Jun 30, 2025 | 28.22 Mn |
| Mar 31, 2025 | 26.17 Mn |
| Dec 31, 2024 | 30.60 Mn |
| Sep 30, 2024 | 29.56 Mn |
| Jun 30, 2024 | 30.72 Mn |
| Mar 31, 2024 | 29.02 Mn |
| Dec 31, 2023 | -2.90 Mn |
| Sep 30, 2023 | 41.47 Mn |
| Jun 30, 2023 | 44.30 Mn |
| Mar 31, 2023 | 37.92 Mn |
| Dec 31, 2022 | -2.79 Mn |
| Sep 30, 2022 | 40.26 Mn |
| Jun 30, 2022 | 39.66 Mn |
| Mar 31, 2022 | 36.69 Mn |
| Dec 31, 2021 | 35.82 Mn |
| Sep 30, 2021 | 39.54 Mn |